INFEX Therapeutics
Kevin Blades is a Senior Research Scientist with extensive experience in developing new drugs for the treatment of gram negative bacteria. Kevin has worked at companies such as AMR Centre Ltd, Redx Pharma, and AstraZeneca. Kevin also has a background in organo fluorine chemistry, having obtained a Doctor of Philosophy degree from the University of Birmingham. Prior to their industry roles, Kevin served as a Post Doc at the University of Manchester where Kevin made significant contributions towards the development of new synthetic methodologies.
This person is not in any teams
INFEX Therapeutics
We acquire, develop and license innovative drugs to treat pandemic infections. We have expanded to develop a broader portfolio of new therapies to meet the rising burden of critical priority infectious disease. Based at Alderley Park in the North West of England, our work addresses unmet patient needs and will bring new portfolio of drugs into clinical trials to treat patients suffering from life-threatening infections.